LB PHARMACEUTICALS INC — Form D/A
LB PHARMACEUTICALS INC of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2022-11-23. The offering totals $40.0M, of which $16.6M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2022-11-23
- Form: D/A
- Accession: 0001567619-22-020814
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $40.0M
- Amount sold: $16.6M
- Remaining: $23.4M
- Minimum investment: $25K
- Investors: 71
- Date of first sale: 2022-10-21
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-463476
Issuer
- Name: LB PHARMACEUTICALS INC
- CIK: 0001691082
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 575 MADISON AVENUE, NEW YORK, NY, 10022
- Phone: 212-605-0230
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Vincent Grattan | Director | New York, NY |
| Piero Poli | Director | New York, NY |
| Edmund Sullivan | Director | New York, NY |
| Simon Basseyn | Director | New York, NY |
| CHEN YU | Director | PALO ALTO, CA |
| Rebecca Luse | Director | Boston, MA |
| Robert Ruffolo | Director | Boston, MA |
| Rajul Jain | Director | South San Francisco, CA |
| Ran Nussbaum | Director | New York, NY |
| Zachary Prensky | Director | New York, NY |
| Zachary Prensky | Executive Officer | New York, NY |
| Andrew Vaino | Executive Officer | New York, NY |
| Anna Eramo | Executive Officer | New York, NY |
| Marc Panoff | Executive Officer | New York, NY |
| Mark Panoff | Executive Officer | New York, NY |
| Lauren Stipp | Executive Officer | New York, NY |
Other filings by this issuer (10)
More